Drug
Cin 107
Cin 107: highest development phase Phase 2, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| CIN-107 NCT05459688 | Phase 2 | Hypertension |
Latest
No recent events.
Follow Cin 107 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.